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Abstract
The 3-O-sulfotransferase (3-OST) family catalyzes rare modifications of glycosaminoglycan chains on heparan sulfate
proteoglycans, yet their biological functions are largely unknown. Knockdown of 3-OST-7 in zebrafish uncouples cardiac
ventricular contraction from normal calcium cycling and electrophysiology by reducing tropomyosin4 (tpm4) expression.
Normal 3-OST-7 activity prevents the expansion of BMP signaling into ventricular myocytes, and ectopic activation of BMP
mimics the ventricular noncontraction phenotype seen in 3-OST-7 depleted embryos. In 3-OST-7 morphants, ventricular
contraction can be rescued by overexpression of tropomyosin tpm4 but not by troponin tnnt2, indicating that tpm4 serves
as a lynchpin for ventricular sarcomere organization downstream of 3-OST-7. Contraction can be rescued by expression of 3-
OST-7 in endocardium, or by genetic loss of bmp4. Strikingly, BMP misregulation seen in 3-OST-7 morphants also occurs in
multiple cardiac noncontraction models, including potassium voltage-gated channel gene, kcnh2, affected in Romano-Ward
syndrome and long-QT syndrome, and cardiac troponin T gene, tnnt2, affected in human cardiomyopathies. Together these
results reveal 3-OST-7 as a key component of a novel pathway that constrains BMP signaling from ventricular myocytes,
coordinates sarcomere assembly, and promotes cardiac contractile function.
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Introduction
Vertebrate heart development requires an accurate integration of
patterning and morphogenetic events, leading eventually to the
formation of a fully functional heart. It initiates with the specification
of the different tissue lineages that will compose the mature heart,
followed by an intricate set of differentiation events that will
transform the early heart field into a mature, beating organ. This
transformation is defined by the subspecialization of regions of the
primitive heart tube to acquire characteristics of contractile
myocardium or region-specific maintenance of noncontracting
myocardium. These complex events are orchestrated by a network
of signals and transcription factors that could act differentially
depending upon specific spatiotemporal cues. Among the important
players are major signaling pathways such as BMP signaling and
Wnt signaling, which set the early stages of differentiation [1–4], and
the T-box (Tbx) family of transcription factors that confer chamber
or nonchamber identity to the primitive heart tube [5].
Ultimately, generation of a beating heart is the goal of these
processes. For the heart to contract, contractile proteins must be
produced and assembled into sarcomeres and their contraction
must be coupled to the cycling electrophysiological activity. The
heart starts beating during the late stages of heart tube formation
and through its mechanical action, affects subsequent differenti-
ation steps as shown in studies correlating defective morphogenesis
with abnormal function [6–9]. Despite this understanding of heart
development, critical questions remain in the field and unknown
players remain to be discovered. In this study, we focus on the role
in heart development of an enzyme, 3-O-sulfotransferase-7 (3-
OST-7), that modifies heparan sulfate proteoglycans (HSPGs).
HSPGs are cell surface and extracellular matrix (ECM)
molecules composed of a core protein to which glycosaminoglycan
(GAG) chains are covalently linked. The ability of HSPGs to
interact with signaling ligands and receptors and ECM compo-
nents place them at a unique advantage to modulate complex
biological processes such as morphogenesis, tissue repair, and host
defense [10–12]. The specificity of interactions of an HSPG and its
environment is due, in part, to the GAG chains [12–14]. The
GAG chains in HSPGs are unbranched, charged polysaccharides
composed of 50 or more repeating disaccharide units of N-
acetylglucosamine and glucuronic acid. These chains are subjected
to several kinds of modifications: N-deacetylation/N-sulfation,
epimerization, and O-sulfation. Not all disaccharide residues are
modified, resulting in GAG chains with relatively small clusters of
modified units interspersed among large sections of unmodified
units [15]. This gives rise to an astounding level of structural
PLOS Biology | www.plosbiology.org 1 December 2013 | Volume 11 | Issue 12 | e1001727
heterogeneity, producing GAG chains with varying specificities for
protein binding [10]. The repertoire of modifying enzymes differs
between cells [10], which in theory could impact how a cell
interacts with a ligand, a neighboring cell, or the ECM. Previous
gene knockdown and knockout studies have begun to document
the roles for these modifying enzymes [14], but none has been
implicated in heart development.
In this study, we focus on a rare and specific kind of O-sulfation,
3-O-sulfation, performed by a family of enzymes, the 3-O-
sulfotransferases (3-OSTs). 3-OSTs catalyze transfer of a sulfate
group to the hydroxyl of the third carbon of N-sulfated
glucosamine residues [15]. Previous work in our lab has identified
and cloned the 3-OST family in zebrafish [16]. Gene expression
analysis reveals dynamic spatial and temporal expression patterns
for the eight 3-OST family members suggesting distinct roles in
the developing embryo.
Here we show that morpholino (MO) knockdown of one of
eight 3-OST family members in zebrafish, 3-OST-7 (aka hs3st1l1),
specifically results in a noncontracting cardiac ventricle at
48 hours post fertilization (hpf). Surprisingly, electrical and
calcium transients in cardiomyocytes appear to be normal,
suggesting that normal electrophysiological signaling in cardiomy-
ocytes is uncoupled from cardiomyocyte contraction. Further
exploring the noncontracting phenotype, we show that 3-OST-7
functions to negatively regulate BMP signaling in cardiomyocytes
and to allow tpm4 mRNA accumulation, which then allows normal
sarcomere organization and contraction. The roles of 3-OST-7
and BMP signaling reveal a novel mechanism for the regulation of
cardiac cell function.
Results
Cardiac Ventricle Contraction Requires 3-OST-7
To begin elucidating the role of 3-OST-7 in development, we
injected zebrafish embryos with either a translation-blocking MO
(MO1) or a splice-blocking MO (MO2). Knockdown with MO2
was verified by reverse transcription (RT)-PCR analysis (Figure 1I).
Embryos injected with either MO exhibited similar phenotypes
indicative of a cardiovascular phenotype: pericardial edema and
blood pooling at 48 hpf (Figure 1A and 1B). Visualizing the heart
in living transgenic Tg(cmlc2:gfp) zebrafish [17] revealed that 3-
OST-7 morphants had a hypoplastic cardiac ventricle that did not
contract normally (Figure 1F and 1G; Video S2), resulting in poor
blood circulation (Video S4). In contrast, sibling control embryos
had normal cardiac contraction cycles, with sequential diastole
and systole, and normal blood circulation (Figure 1C and 1D,
Videos S1 and S3). In contrast to the ventricle in 3-OST-7
morphants, atrium contraction was normal and similar to control
(Figure 1C, 1D, 1F, and 1G). In embryos injected with MO2, only
47%61% (n=124) had normal ventricular contraction, whereas
all control embryos had normal cardiac contraction (n=137)
(Figure 1J).
To assess the specificity of 3-OST-7 knockdowns, we injected
MOs against two other members of the 3-OST family, 3-OST-5
and 3-OST-3z, and found that MO-injected embryos had normal
cardiac ventricular contraction (Figure 1J). Knockdown of 3-OST-
5 and 3-OST-6 resulted in other distinct phenotypes, including
altered cilia function and left-right patterning [18]. Together, these
results indicate that ventricular cardiac contraction defects are a
specific phenotype of 3-OST-7 knockdown, and not knockdown of
other members of the 3-OST family, including 3-OST-5, a
member of the same subgroup as 3-OST-7.
In order to determine what is causing the hypoplasticity of the
3-OST-7 morphant ventricle, we examined cell number and cell
volume. Utilizing the transgene Tg(cmlc2-DsRed-nuc) [19], which
labels cardiomyocyte nuclei, we counted the total number of
cardiomyocytes in both control embryos and 3-OST-7 morphants.
The cardiomyocyte cell number was similar in control (298610,
n=10) and 3-OST-7 morphant (288612, n=10), indicating that
changes in cell number were not the cause for the hypoplastic
ventricle in 3-OST-7 morphants. In contrast, by measuring
ventricular myocyte volume in 3D-reconstructions of optical
sections of the cardiac tube, we found that the cellular volume
of individual ventricular myocytes was significantly reduced in 3-
OST-7 morphants compared to control embryos (Figure 1E and
1H, p=0.01), thus suggesting that cell shape changes were
correlated with the observed hypoplasticity of 3-OST-7 morphant
ventricles. Individual atrial myocyte volume was similar (p=0.10)
between control (207611 mm3, n=7) and 3-OST-7 morphant
(183611 mm3, n=10).
Expression of 3-OST-7 in Endocardium Rescues
Contraction in Myocardium
When using MOs to knockdown gene function, an important
control is to rescue MO phenotype by co-expression of the
targeted gene. We utilized the Tol2kit cloning system [20] to
create stable, germline-transmitted transgenic Tg(b-actin:3-OST-7-
IEP) zebrafish that expressed 3-OST-7 under the control of the b-
actin promoter for ubiquitous expression throughout early devel-
opment. To preclude inhibition of transgenic expression of 3-
OST-7, the MO binding sequence is not present in the construct.
We placed an IRES-EGFP-polyA (IEP) downstream of the 3-
OST-7 coding region, which enabled identification of individual
transgenic embryos expressing 3-OST-7 by co-expression of
EGFP. Constitutive expression of 3-OST-7 reduced the contrac-
tion defect in 3-OST-7 morphants, compared to nontransgenic
morphants (Figure 1K).
3-O-sulfotransferases modify HSPGs, which typically function
at the cell surface, making it possible that they modulate cell-cell
Author Summary
A highly complex environment at the cell surface and in
the space between cells is thought to modulate cell
behavior. Heparan sulfate proteoglycans are cell surface
and extracellular matrix molecules that are covalently
linked to long chains of repeating sugar units called
glycosaminoglycan chains. These chains can be subjected
to rare modifications and they are believed to influence
specific cell signaling events in a lineage specific fashion in
what is called the ‘‘glycocode.’’ Here we explore the
functions of one member of a family of enzymes, 3-O-
sulfotransferases (3-OSTs) that catalyzes a rare modifica-
tion (3-O-sulfation) of glycosaminoglycans in zebrafish. We
show that knockdown of 3-OST-7 results in a very specific
phenotype, including loss of cardiac ventricle contraction.
Knockdown of other 3-OST family members did not result
in the same phenotype, suggesting that distinct 3-OST
family members have distinct functions in vertebrates and
lending in vivo evidence for the glycocode hypothesis.
Mechanistically, we found that cardiac contraction can be
rescued by reducing the amount of endogenous BMP4,
and can be blocked by increasing BMP signaling, suggest-
ing that the glycocode generated by 3-OST-7 is necessary
to constrain BMP signaling in the heart for normal cardiac
contraction. Furthermore, we show that tropomyosin4
(tpm4) is downstream of 3-OST-7 function, indicating that
Tpm4 is key in this pathway to building the sarcomere, the
functional contraction unit of the cardiomyocyte.
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Figure 1. 3-OST-7 is required for ventricular contraction in the zebrafish heart. Lateral views of control (uninjected, wild-type) (A) and 3-
OST-7 morphant (B) embryos at 48 hpf showing edema (red arrowhead) and blood pooling (black arrowhead) with knockdown of 3-OST-7. Lateral
views of hearts in control (C–D) and 3-OST-7 morphant (F–G) Tg(cmlc2:gfp) embryos at periods of ventricular diastole (C and F) and systole (D and G).
3D-reconstructed ventricular cell in control (E) and 3-OST-7 morphant (H) embryos show decreased volume (V) in morphants. (I) Gene structure of 3-
OST-7 showing MO targets (red for MO1 and green for MO2) and primer sets used for RT-PCR analysis (blue and orange bars). RT-PCR analysis
showing decrease in spliced and increase in unspliced products with increasing dose of MO injected. (J) Percentage contraction of embryos in
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signaling into 3-OST-expressing cell and/or into neighboring
cells. 3-OST-7 is expressed ubiquitously early in development
[16]. In the ventricle at 48 hpf, the myocardium is directly
apposed to the endocardium, so either cell lineage could be a
source for 3-OST-7 function. To refine our understanding of 3-
OST-7 in cardiac ventricular contraction, we asked which
ventricular cell lineage required 3-OST-7 in order to allow
normal ventricular contraction. We created stable transgenic
zebrafish lines that express 3-OST-7 under the control of the cmlc2
(aka myl7) promoter in myocardial-specific lineages, or expressing
3-OST-7 under the control of the fli1 promoter in endothelial/
endocardial-specific lineages. The 3-OST-7 MO binding sequence
is not present in either construct, therefore the MO would not
inhibit transgenic expression of 3-OST-7. Both transgenes have an
IRES-EGFP tag downstream of 3-OST-7 coding region, enabling
identification of embryos that express 3-OST-7 in either endo-
cardium or myocardium by co-expression of EGFP. These
transgenic embryos were injected with 3-OST-7 MO and
compared with nontransgenic, MO-injected sibling embryos. We
observed significant rescue of ventricle contraction in morphants
in which 3-OST-7 was expressed in endocardium, Tg(fli1:3-OST-
7-IEP), that was comparable to rescue by ubiquitously expressed
3-OST-7 in transgenic Tg(b-actin:3-OST-7-IEP) morphants
(Figure 1K). In contrast, transgenic expression of 3-OST-7 in
cardiomyocytes by Tg(cmlc2:3-OST-7-IEP) was not sufficient to
rescue cardiac contraction (Figure 1K). While the fli1 driver
rescues to the same extent as the ubiquitous driver, it is possible
that other tissues might also utilize 3-OST-7. Also, it should be
noted that it is not possible to conclude that 3-OST-7 is not also
required in cardiomyocytes earlier in development. Transgenic
cmlc2 expression begins at approximately 16 hpf, while the fli1-
driven transgene starts being expressed at approximately 12 hpf,
as assessed by co-expression of EGFP with 3-OST-7 (unpublished
data). Thus, it is possible that the inability of the cmlc2:3-OST-7
transgene to rescue is due to expression that is too late to be
effective. Nonetheless, these results indicate that expression of 3-
OST-7 in endocardium is sufficient to rescue the contraction of
myocardium, suggesting 3-OST-7 functions to regulate cell-cell
signaling across these apposed tissues.
Early Patterning in 3-OST-7 Morphants Is Normal
We explored several possible causes of ventricular noncontrac-
tion in 3-OST-7 morphants, including alterations in cardiac
patterning or cardiomyocyte development. We used in situ
hybridizations (ISH) and transgenic fish to assess whether the
heart field is correctly specified in 3-OST-7 morphants. Hand2 and
nkx2.5, whose combined expressions define cardiac precursor cells
in the lateral plate mesoderm [21], have similar expression
patterns in both control embryos and 3-OST-7 morphants (Figure
S1A–S1D). Similarly, expression patterns of cmlc2 (myocardial
marker), amhc (atrial marker), and vmhc (ventricular marker) were
unaltered in 3-OST-7 morphants (Figure S1E and S1F, S1I–S1L).
Endocardial precursor patterning was similar in control and 3-
OST-7 embryos (Figure S1G and S1H), as assessed in
Tg(fli1:EGFP embryos) [22]. Together these results demonstrate
that heart field specification, early endocardial development, and
myocardial development proceed normally in 3-OST-7 mor-
phants, and that early mispatterning is not likely the cause for the
noncontracting ventricle.
Noncontracting Ventricle in 3-OST-7 Morphants
Generates Normal Action Potentials and Calcium
Transients
To determine whether ventricular noncontraction in 3-OST-7
morphants was due to defects in cardiomyocyte physiology, we
assessed coupling of contraction to excitation. A fully functional
heart characteristically undergoes excitation-contraction coupling,
a physiological process whereby an electrical stimulus (action
potential) is converted to a mechanical response (contraction) [23].
We first assessed whether the morphant ventricle could generate
action potentials and calcium transients. To record action
potentials, we performed patch clamp analysis on either the
atrium or ventricle (Figure 2A and 2B) as previously described
[24]. As expected, atria of 3-OST-7 morphants generated action
potentials comparable to atria of control embryos (Figure 2C and
2D). Surprisingly, however, action potentials were also obtained
for the noncontracting ventricles of 3-OST-7 morphants and these
action potentials were similar to those recorded for ventricles of
control embryos (Figure 2E and 2F). Moreover, analysis of action
potential parameters revealed that there were no statistically
significant differences between control embryos and 3-OST-7
morphants (Tables S1 and S2). These results indicate that the ion
channels responsible for generating and propagating these action
potentials were intact and physiologically functional in 3-OST-7
morphants.
A primary function of the cardiac action potential is to trigger
the increase in intracellular calcium that initiates cardiac
contraction [25]. To assess whether this increase occurs in 3-
OST-7 morphant ventricles, we used two different techniques to
image changes in intracellular calcium. In the first technique,
explanted embryonic hearts were imaged by high-speed confocal
microscopy using the calcium indicator Fluo-4. The amplitude and
the decay of recorded calcium transients were measured to assess
the release and re-uptake of intracellular calcium. Similar calcium
waves were observed in hearts of both control embryos and 3-
OST-7 morphants (Videos S5 and S6). The 3-OST-7 morphant
atria and ventricles generated calcium transients (Figure 2H and
2J) similar to those generated by atria and ventricles from control
embryos (Figure 2G and 2I). There were no significant differences
in the calcium transient amplitude and calcium transient decay
between ventricles of 3-OST-7 morphant embryos and ventricles
of control embryos (Figure 2K and 2L). In the second technique,
3-OST-7 MO or control MO was injected into transgenic
Tg(cmlc2:gCaMP)s878 embryos [26] that allowed for live calcium
imaging in intact zebrafish. Similar to the other technique, calcium
waves were detected in 3-OST-7 morphant hearts (Videos S7 and
S8) and comparable optical maps were generated for both control
embryos and 3-OST-7 morphants (Figure 2M and 2N). There
were no observed differences in conduction velocity. Together
these results demonstrated the ability of the noncontracting
different 3-OST knockdowns (3-OST-7, 3-OST-5, 3-OST-3Z). Only knockdown of 3-OST-7 MO resulted in ventricular noncontraction. (K) Percentage
contraction of embryos in rescue experiments using three different transgenes. Uninjected embryos with (green bar) or without (white bar) the
transgene had normal ventricular contraction. Injection of 3-OST-7 MO2 in Tg(b-actin:3-OST-7-IEP) and Tg(fli1:3-OST-7-IEP) embryos rescued the
noncontracting ventricle phenotype (p= 0.039 and p= 0.0036, respectively, *). Injection of 3-OST-7 MO2 in Tg(cmlc2:3-OST-7-IEP) did not rescue the
phenotype (p=0.44, NS). Graphs depict the percentage of embryos with phenotype in 3-OST-7-overexpressing (GFP+, green hatched) or non-3-OST-
7-overexpressing (GFP-, white hatched) embryos from individual crosses between one of three transgenic founders and wild-type AB zebrafish. At,
atrium; V, ventricle; error bars, SEM.
doi:10.1371/journal.pbio.1001727.g001
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ventricle of 3-OST-7 morphants to release calcium from the
sarcoplasmic reticulum and to re-uptake it at the end of the cycle.
These results indicate that the intracellular components that are
critical for calcium cycling are functional in 3-OST-7 morphants.
In addition, the normal propagation of calcium waves in 3-OST-7
morphant hearts indicates that the gap junctions and excitatory
ion currents critical for normal cell-cell conduction were also
intact.
3-OST-7-Dependent Expression of Tpm4 Is Required for
Myofibrillogenesis, Sarcomere Assembly, and Contraction
Our observations that action potentials and calcium transients
were normal in 3-OST-7 morphants with noncontracting ventricles
indicate that excitation was uncoupled from contraction. Moreover,
this suggests that the failure of contraction in 3-OST-7 morphants
might be due to defects in the myocardial contractile apparatus,
which is the direct target of calcium ions released from the
sarcoplasmic reticulum during electrical excitation of the heart. To
determine whether ventricular noncontraction of 3-OST-7 mor-
phants is due to aberrant sarcomeres, we used immunohistochem-
istry (IHC) and transmission electron microscopy (TEM) to visualize
the sarcomeric structure of the heart. Using MF20 and phalloidin to
stain sarcomeric myosin and the actin filaments, respectively, we
found that these filaments were disorganized in 3-OST-7 morphant
hearts compared to the orderly filament organization in hearts of
control embryos (Figure S2). IHC analysis also showed diminished
cardiac troponin T (Tnnt2) and tropomyosin (Tpm) organization in
3-OST-7 morphant hearts (Figure 3B and 3F) compared to control
embryo hearts (Figure 3A and 3E). Myofibrils with distinct
sarcomeric structures such as A-bands, I-bands, and Z-discs were
evident by TEM in control hearts (Figure 3C). In contrast, the
myofibrils were reduced and disorganized in 3-OST-7 morphant
hearts (Figure 3G). Together these results demonstrate the
noncontraction of the ventricle in 3-OST-7 morphants is correlated
with disorganization of sarcomere proteins.
Figure 2. Noncontracting ventricle in 3-OST-7 morphants
generates normal action potentials and calcium transients. (A)
Zebrafish embryos were injected with 3-OST-7 MO1 at one-cell stage
and allowed to develop until 48 hpf. The heart was then dissected out
of the embryo and either placed in a recording chamber perfused with
external control solution (for action potential analysis) or incubated in
Fluo-4 and imaged using a confocal microscope (for calcium transient
analysis). Control 48 hpf hearts from uninjected embryos or injected
with control 3-OST-5 MO were processed in parallel. (B) A suction
pipette was used to patch clamp the heart at the atrial or ventricular
region. Action potentials were recorded from atria (C–D) and ventricles
(E–F) of control (uninjected, WT) (C and E) and 3-OST-7 morphant (D and
F) embryos. The action potentials were comparable between control
and 3-OST-7 morphant embryos. Regions were selected from atrium
and ventricle to record the calcium transients (G–J) and measure the
Ca2+ transient amplitude (K) and Ca2+ transient decay (L) (error bars,
SEM). No significant difference was detected between control and 3-
OST-7 morphant embryos (p= 0.30 for atrial transient amplitude;
p=0.16 for ventricular transient amplitude; p= 0.37 for atrial transient
decay; and p= 0.51 for ventricular transient decay). In the second
technique to image the calcium transients, 3-OST-7 MO1 or control 3-
OST-3Z MO was injected into Tg(cmlc2:gCaMP)s878 embryos at one-cell
stage and allowed to develop until 48 hpf. Optical maps of calcium
activation for a single cycle, represented by isochronal lines every
20 ms, show calcium activation and conduction velocity proceed
normally in 3-OST-7 morphants (N) compared to control MO injected
embryos (M). Conduction proceeds from the atrium through the AV
canal to the ventricle and numbers indicate the temporal sequence of
calcium activation. Color bar chart fluorescence intensity changes on a
scale of 0 to 100. b.a., bulbus arteriosus.
doi:10.1371/journal.pbio.1001727.g002
3-OST-7 Regulates BMP and Cardiac Contraction
PLOS Biology | www.plosbiology.org 5 December 2013 | Volume 11 | Issue 12 | e1001727
Since it appears that 3-OST-7 is required for sarcomere
organization, and for Tnnt2 and Tpm protein levels (Figure 3B
and 3F), we asked whether 3-OST-7 MO affects RNA transcript
accumulation for either of these sarcomeric genes. ISH analysis of
tnnt2 RNA expression at 20 hpf, 24 hpf, and 48 hpf in morphants
revealed that tnnt2 transcript levels were similar to control (Figure
S3A, S3B, S3E, S3F, S3I, S3J). In contrast, transcript levels of tpm4
were reduced in 3-OST-7 morphants compared to control
embryos (Figures 3D, 3H, S3C, S3D, S3G, and S3H). In hearts
obtained by bulk disruption of 48 hpf embryos [27], tpm4
transcript levels were reduced 3.8-fold in 3-OST-7 morphants
(p=6.261024), as assessed by microarray analysis. Similar to ISH
data, tnnt2 transcript levels were unchanged in the microarray
analysis (p.0.05). Together, these results suggest that 3-OST-7
MO leads to a reduction of tpm4 RNA accumulation, which then
leads to reduced Tpm protein accumulation.
We suggest that cardiac Tpm4 serves as a ‘‘lynchpin’’ protein
downstream of 3-OST-7 function; when Tpm4 is reduced,
sarcomeres fail to be stably organized, and other sarcomeric
proteins are degraded in response. Consistent with this idea, tnnt2
RNA is present but Tnnt2 protein is diminished in 3-OST-7
morphants. We predicted that if Tpm4 serves as a lynchpin
protein in 3-OST-7 function, then we should be able to rescue
sarcomere organization and ventricular contraction in 3-OST-7
morphants by injection of tpm4 RNA. Injection of tpm4 RNA alone
in control embryos had no perceived gross morphological effect,
nor did it alter cardiac function (Figure S4). Strikingly, injection of
tpm4 RNA in 3-OST-7 morphants rescued ventricular contraction
as assessed by looking at contraction in 48 hpf embryos
(p=0.0097, Figure S4) and by measuring ejection area (p,0.05,
Figure 3L). In keeping with the rescued ventricular contraction,
tpm4 RNA injection in 3-OST-7 MO also rescued the organization
Figure 3. 3-OST-7 regulates tpm4-driven myofibrillogenesis, sarcomere assembly and ventricular contraction. Whole mount IHC was
performed on fixed 48 hpf control (injected with control 3-OST-3Z MO) or 3-OST-7 morphant embryos to detect cardiac sarcomere proteins (n= 30
for each group). The heart was then dissected out of the embryo, mounted on cover slips, and imaged using a confocal microscope (thus, the dorso-
ventral orientation of the mounted hearts was random). IHC using anti-Tnnt2 antibody and anti-Tpm antibody revealed levels of these proteins were
greatly reduced in 3-OST-7 morphants (B and F, dashed lines outline the hearts) compared to control (A and E) embryos. TEM of control (C) and 3-
OST-7 morphant (G) hearts show the presence of organized myofibrils (red arrowheads) in control and absence in morphants. ISH for tpm4 showed
tpm4 transcript levels were decreased in 3-OST-7 morphants (H) compared to control embryos (D) at 48 hpf. (D and H) are ventral views with anterior
on top; n= 40 for each group. Overexpression of tpm4 rescues the expression of Tnnt2 (I) and Tpm (J) proteins, assembly of myofibrils (K), and the
noncontracting ventricle phenotype in 3-OST-7 morphant embryos as assessed by ejection area measurements (L, p,0.05, *). The ejection area, a
measure of contractility, was obtained by computing the difference between systolic and diastolic area for either atrium or ventricle. At, atrium; V,
ventricle; error bars, SEM.
doi:10.1371/journal.pbio.1001727.g003
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and expression of sarcomeric proteins Tnnt2 and Tpm, and
rescued the TEM appearance of sarcomeric structures in
myofibrils (Figure 3I–3K). In contrast with the ability of tpm4
RNA to rescue cardiac contraction in 3-OST-7 morphants,
transient transgenic expression of tnnt2 did not rescue cardiac
contraction. As a control, embryos that were transgenic for a
construct that drives cardiac expression of tnnt2-IRES-EGFP under
the control of the cmlc2 promoter had normal cardiac contraction.
3-OST-7 MO injected into this transgenic (scored by EGFP
expression) resulted in decreased cardiac contraction, at frequen-
cies comparable to 3-OST-7 MO in non-transgenic siblings
(Figure S5). Together these results demonstrate that Tpm4 serves
as a downstream lynchpin of 3-OST-7 function for normal cardiac
ventricular contraction.
Chamber Patterning, FGF, and Notch Signaling are
Normal in 3-OST-7 Morphants
In addition to myofibrillogenesis and onset of contraction, the
cardiac maturation program involves a comprehensive patterning
of myocardial cells into either contracting chamber myocardium
(atrium or ventricle) or nonchamber, noncontracting myocardium
(sinus venosus, atrioventricular or AV canal, and outflow tract)
[28,29]. To determine whether this patterning occurs in 3-OST-7
morphants, we performed ISH for tbx2 (tbx2b in zebrafish) and anf
in 48 hpf control embryos and 3-OST-7 morphants. Tbx2b is
normally expressed in the AV canal (nonchamber myocardium) at
48 hpf [30], and we observed a similar pattern of expression in
both control embryos and 3-OST-7 morphants (Figure 4A and
4D). Similarly, anf, which is normally expressed in atrium and
ventricle (chamber myocardium) at 48 hpf, had a similar pattern
of expression in 3-OST-7 morphants (Figure S7C and S7D).
Together these results suggest that 3-OST-7 morphants undergo
normal patterning and segregation of chamber and nonchamber
myocardium.
We also investigated whether two major developmental
signaling pathways, FGF and Notch signaling, are involved in 3-
OST-7 regulation of ventricular contraction. FGF signaling was a
strong candidate because it requires HSPG GAG chains for
receptor-ligand complex formation [13,31–33]. If loss of contrac-
tion caused by knockdown of 3-OST-7 occurs through deficient
FGF signaling, direct perturbation of FGF signaling should mimic
the noncontracting ventricle phenotype of 3-OST-7 morphants.
However, FGF receptor 1 (fgfr1) knockdown resulted in ventricles
that were smaller but had normal contractility (Figure S6A).
Similarly, reducing or abolishing FGF signaling either in the
zebrafish fgf8/ace mutant or by treatment with the FGFR inhibitor
SU5402 also resulted in small hearts with particularly notable
reductions of the ventricle, but no reported alterations in
contraction [34,35]. The normal cardiac contraction in FGF
pathway manipulations suggests that FGF signaling is not a
component of the 3-OST-7-dependent pathway.
In Drosophila, the Notch pathway is dependent on 3-O-sulfation
by 3-OST-B [36]. More importantly, deltaD, a Notch ligand, was
one of the most downregulated genes in the microarray analysis
comparing control embryo hearts and 3-OST-7 morphant hearts
at 48 hpf (7.0-fold decreased, p=1.8661022). To determine
whether 3-OST-7 regulates ventricular contraction by way of
the Notch signaling pathway, we assessed whether the noncon-
tracting ventricle phenotype is recapitulated in deltaD/aeiAG49
mutant embryos [37]. Embryos carrying a homozygous mutation
in the deltaD gene were identified by misshapped somites posterior
to the ninth somite [37] and separated from wild-type or
heterozygous siblings at 18 hpf. The hearts were then scored for
ventricular contraction at 48 hpf. Cardiac contraction was normal
in deltaD/aeiAG49 mutants (n=34 mutants; n=94 wild-type
siblings). Since DeltaD is one of four Delta ligands in zebrafish,
it is possible that other Delta ligands might be compensating for
loss of DeltaD in deltaD/aeiAG49 mutants. To more broadly block
Notch signaling, we used DAPT, a c-secretase inhibitor. Contin-
uous treatment from 5 hpf, when cells are fated to become
myocytes [38], to 48 hpf did not result in ventricular noncontrac-
tion at 48 hpf (Figure S6B), but disrupted somite formation,
indicative of treatment efficacy. Treatments during narrower
developmental windows gave similar results, with normal cardiac
contraction (Figure S6B). Together these results suggest that Notch
signaling is not a component of the 3-OST-7-dependent pathway
for cardiac contraction.
BMP Signaling Is Expanded in 3-OST-7 Morphants
Bmp4, versican, and notch1b expression patterns are progressively
restricted to the AV junction during cardiac development. All
three genes are expressed along the antero-posterior length of the
heart at 24 hpf and are subsequently restricted to the AV canal
and excluded from expression in the maturing ventricle by 48 hpf
(Figures 4B, 4C, and S7A), as previously reported [39–41].
However, in contrast to controls, in 3-OST-7 morphants bmp4
(Figure 4F) and versican (Figure S7B) were ectopically expressed in
ventricles at 48 hpf. Bmp4 and versican remained ectopically
expressed in ventricular myocytes at 3 days postfertilization
(n=40 embryos). In contrast to bmp4 and versican, notch1B was
expressed solely in the AV canal of 3-OST-7 morphants
(Figure 4E), similar to control embryos, and tie2 expression,
assessed in Tg(tie2:EGFP) embryos, was expressed normally in the
AV canal in both control and 3-OST-7 morphant embryos (Figure
S7E and S7F). Normal notch1B and tie2 expression suggest that the
failure of bmp4 and versican to become AV canal-restricted was not
merely due to developmental delay, nor to an overall mispattern-
ing of AV boundaries. Together these results indicate 3-OST-7
morphant hearts achieve normal AV boundary formation, but fail
to exclude bmp4 expression from ventricular myocytes.
To investigate whether ectopic expression of bmp4 in the
ventricle affects BMP signaling, we performed IHC for phosphor-
ylated-Smad1/5/8 (P-Smad), a downstream marker for Bmp
signaling. P-Smad was localized most strongly in the nuclei of AV
canal cells in control hearts (Figure 4G), which corresponds to
bmp4 being normally restricted to that region at 48 hpf. In
contrast, P-Smad was found strongly expressed in the nuclei of
ventricular cells in 3-OST-7 morphant hearts as well as in nuclei of
AV canal cells (Figure 4H), which corresponds to the ectopic
expression of bmp4 in the ventricle. In order to quantify this effect,
we divided the ventricle images into six domains (domain 1
contains the AV junction and domain 6 was the region farthest
from the AV junction) and counted the number of P-Smad-
positive nuclei within each domain (Figure 4I). In 3-OST-7
morphants, an increased number of P-Smad-positive nuclei were
present even in the domains farthest from the AV, while there
were very few P-Smad positive nuclei outside the AV domain in
control hearts. Interestingly, the number of P-Smad positive nuclei
in 3-OST-7 morphants appears as a gradient, with the highest
numbers close to the AV junction (Figure 4I). We also utilized the
transgenic Tg(BRE:d2GFP) fish [42] to visualize dynamic tran-
scriptional response to BMP signaling in live embryos. In control
embryos, GFP expression in the heart was observed primarily in
the AV junction (Figure 4J and 4K). In contrast, GFP expression
was expanded to the whole ventricle in 3-OST-7 morphants
(Figure 4L and 4M), in keeping with the expanded bmp4 RNA
expression and the expanded P-Smad nuclear staining. These
results suggest that the role of 3-OST-7 is to confine bmp4
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Figure 4. 3-OST-7 controls region-specific BMP signaling in differentiating heart. ISH for tbx2b (A and D), notch1B (B and E) showed normal
AV-restricted expression, whereas bmp4 expression (C and F) showed ectopic expression in ventricular myocardium of 3-OST-7 morphants at 48 hpf
(n=30 for each group). IHC for P-Smad at 48 hpf showed delocalized expression in nuclei of 3-OST-7 morphant ventricle (H) compared to localized
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expression and downstream BMP response to the AV junction,
and to prevent BMP signaling from spreading into ventricular
myocardium at 48 hpf.
To investigate whether other components of the BMP signaling
pathway are involved in the 3-OST-7 morphant phenotype, we
performed ISH analysis on nine BMP receptors at four different
developmental timepoints (17 somite stage, 24 hpf, 36 hpf, and
48 hpf): bmpr1aa (alk3a), bmpr1ab (alk3b), bmpr1ba (alk6a), bmpr1bb
(alk6b), bmpr2b, acvr1l (alk8), acvr2aa (acvr2a), acvr2b, and acvrl1 (alk1)
(Table S3). Of these, bmpr2b and alk8 had altered heart expression
in 3-OST-7 morphants, with strongly increased bmpr2b expression
in the heart (Figure S8C) and alk8 expression in the outflow tract
(Figure S8D) that were not observed in controls (Figure S8A and
S8B).
Ectopic Ventricular Expression of Bmp4 Occurs in Two
Other Models of Noncontraction
The expansion of BMP signaling into the ventricular myocar-
dium in 3-OST-7 morphants provides a correlation between
absence of ventricular contraction and expanded or ectopic
expression of bmp4 in ventricular myocardium. To determine
whether this correlation occurs in other distinct pathways that lead
to defective contraction, we examined bmp4 expression in
morphants of the potassium channel gene kcnh2 and sarcomeric
protein cardiac troponin T gene tnnt2. Kcnh2 and tnnt2 mutants
both have ‘‘silent’’ (i.e., noncontracting) hearts and MO knock-
down of these genes phenocopy the mutant phenotypes [24,43],
which we scored as percent of embryos with cardiac contraction
defect (Figure 5A).
Bmp4 expression is significantly expanded in the kcnh2 and tnnt2
morphants (Figure 5B), which we classified and scored in three
categories: normal AV-restricted expression (AV only, blue,
Figure 5B), ectopic expression expanded into ventricle (AV+V,
red, Figure 5B), and ectopic expression expanded into both atrium
and ventricle (entire heart, green, Figure 5B). Strikingly, only
23.4% and 5.7% of embryos had normal AV-restricted expression
with injection of kcnh2 and tnnt2MO, respectively (blue, Figure 5B).
Most of the morphants (76.6% and 94.3% for kcnh2 and tnnt2
morphants, respectively) had expanded, ectopic expression of bmp4
in the ventricle (red and green, Figure 5B).
Interestingly, in kcnh2, tnnt2, and 3-OST-7 morphants, the
percentage of ectopic bmp4 expression correlated with percen-
tage of noncontraction (comparing Figure 5B and 5A). For
example, knockdown of 3-OST-7 resulted in 56.9% of embryos
having ventricular noncontraction (Figure 5A) and 48.8% had
ectopic bmp4 expression (red and green, Figure 5B), the least
noncontraction and ectopic bmp4 expression fractions observed
among the three MO knockdowns. In contrast, knockdown of
tnnt2 resulted in 99.4% of embryos with noncontraction
(Figure 5A), the highest noncontraction fraction among the three
knockdowns, which correlated with the highest fraction of ectopic
bmp4 expression (red and green, Figure 5B). These results
demonstrate that the correlation between noncontraction and
ectopic bmp4 expression is conserved in three very distinct models
of defective cardiac contraction.
3-OST-7-Mediated Regulation of Bmp4 Expression Is
Required for Normal Contraction
The above results indicate a correlation between expanded
BMP expression in ventricular myocytes and failure to contract,
but they do not address causality. Is expansion of BMP expression,
as seen in 3-OST-7 morphants, capable of preventing ventricular
contraction? To test the hypothesis that the ectopic expression of
bmp4 in the ventricle causes a noncontracting phenotype, we
utilized the transgenic Tg(hsp70:bmp2b) zebrafish [44] and
performed heat-shock to induce BMP signaling. We crossed
heterozygous Tg(hsp70:bmp2b)/+ fish to wild-type AB and subject-
ed half of the progeny to heat-shock (37uC for 30 min) at 12 hpf,
while leaving the remaining half untreated (Figure 6A). We scored
for ventricular noncontraction, and then confirmed presence of
the heat-shock transgene by PCR. We found that heat-shock at
12 hpf (Figure 6A), but not at 24 hpf and 36 hpf (Table S4),
resulted in ventricular noncontraction.
These results indicate that ectopic overexpression of BMP is
capable of blocking ventricular contraction, but do not test
whether the expanded expression of BMP observed in 3-OST-7
morphants is causative of the noncontracting phenotype. If the
function of 3-OST-7 is to reduce or constrain BMP expression
from ventricular myocytes, and excessive BMP is causative of
contraction defects in 3-OST-7 morphants, then reduction of
AV canal expression in control (G) (n= 10 for each group). (I) Graph depicting increased P-Smad-positive nuclei in the ventricle several unit distances
away from the AV in 3-OST-7 morphants compared to P-Smad-positive nuclei localized in the AV for control (error bars, standard deviation). Imaging
of live Tg(BRE:d2GFP) fish (J and L) showed GFP expression localized to the AV junction in control (K) and expanded expression in ventricle in
morphant (M). V, ventricle; At, atrium; red arrows point to AV; white dashed lines outline the hearts.
doi:10.1371/journal.pbio.1001727.g004
Figure 5. Noncontraction is correlated with ectopic bmp4
expression. (A) Graph comparing the percentage of normal contrac-
tion with 3-OST-7, kcnh2, and tnnt2 MO injections. Error bars, SEM (B)
Graph comparing patterns of bmp4 expression at 48 hpf among control
embryos (injected with 3-OST-5 MO), 3-OST-7 morphants, kchn2
morphants, and tnnt2 morphants. Loss of contraction correlates with
ectopic bmp4 expression in the ventricle (AV+V) or throughout the
entire heart in 3-OST-7, kcnh2 and tnnt2 morphants.
doi:10.1371/journal.pbio.1001727.g005
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endogenous BMP levels in 3-OST-7 morphants should alleviate
the ventricular contraction defect. To test this hypothesis, we
utilized the zebrafish bmp4st72 mutant [45] and asked whether
genetic reduction of bmp4 will rescue the noncontracting ventricle
phenotype caused by knockdown of 3-OST-7. We injected 3-
OST-7 MO into embryos from crosses between bmp4st72/+
heterozygotes, with uninjected embryos from the same genetic
crosses serving as control (Figure 6B). The embryos were then
segregated by cardiac phenotype: normal hearts or noncontracting
ventricles at 48 hpf. In some cases a slight AV morphological
defect was also observed, as part of the bmp4st72 mutant phenotype
seen in both uninjected and injected embryos, and these were
counted among the normally contracting hearts. The individual
embryos were then genotyped. In uninjected embryos, all embryos
displayed normal cardiac contraction, regardless of wild-type,
heterozygous, or homozygous genotype for bmp4st72 (Figure 6B),
indicating that cardiac contraction was not affected in the absence
of 3-OST-7 MO. In siblings that were genotypically wild-type for
bmp4 (+/+) and injected with 3-OST-7 MO, the percentage of
embryos with normal ventricular contraction was only 47.5%,
similar to the range seen in other 3-OST-7 MO experiments
(Figure 6B). Strikingly, the percentage of embryos with normal
cardiac contraction was increased for 3-OST-7 MO injected
bmp4st72 mutants (2/2), with 73.7% of these mutants having a
contracting ventricle (Figure 6B). Genomic DNA sequencing of
the individual injected bmp4st72 mutants confirmed that the 3-
OST-7 MO targeted sequence was correct in bmp4st72 mutants.
These results indicate that reduction of endogenous BMP signaling
is capable of rescuing ventricular contraction in 3-OST-7
morphants. Combined with the observation that ectopic BMP
signaling can cause a noncontracting ventricle phenotype, these
results indicate that 3-OST-7 functions to constrain BMP signaling
to the AV junction and to reduce BMP signaling in the ventricle,
thereby allowing normal cardiac ventricular contraction.
Discussion
In this study we demonstrate that 3-OST-7, one of the enzymes
that places a rare 3-O-sulfation on GAG chains on HSPGs, has a
novel and highly specific function in cardiac development. In 3-
OST-7 knockdown zebrafish, early cardiac cell specification,
patterning, cardiac tube looping, and cardiomyocyte electrophys-
iology are normal, but ventricle contraction is defective. We show
that 3-OST-7 is required for the normal accumulation of tpm4
mRNA in the ventricle. Tpm4 protein appears to be a lynchpin in
ventricular sarcomere assembly and stabilization, because overex-
pression of Tpm4 protein by tpm4 mRNA injection in 3-OST-7
morphants rescues the levels and organization of other sarcomeric
proteins, rescues sarcomere structure, and rescues ventricular
contraction. Tpm4 is also reduced in the atrium in 3-OST-7
morphants, but either this level of reduction is not sufficient to
affect atrial contraction or some other contractile component
might compensate functionally for diminished Tpm4 in the
atrium. In contrast, transgenic overexpression of cardiac troponin
T tnnt2 cannot rescue cardiac contraction in 3-OST-7 morphants.
Thus, knockdown of 3-OST-7 uncouples contraction from the
normally functioning excitation cycle by perturbing tpm4 mRNA
accumulation, leading to defective myofibrillogenesis. This places
the 3-OST-7-dependent 3-O-sulfation of extracellular GAG
chains as the first member of an otherwise unknown signaling
pathway that is upstream of tpm4 regulation and coordinated
sarcomere assembly.
We propose that 3-OST-7 functions in the endocardium by
modifying HSPGs at the interface between endocardium and
myocardium in order to constrain BMP signaling to the AV
junction and dampen BMP signaling in functional myocardium
(Figure 7). The cardiac ventricular contraction defect in 3-OST-7
morphants could be rescued by ubiquitous transgenic expression
of 3-OST-7 and by lineage-specific expression in the endocardi-
um, but surprisingly not by lineage specific expression in the
myocardium. This would suggest 3-O-sulfation of HSPGs by 3-
OST-7 mediates cell-cell communication between myocardium
and endocardium to regulate tpm4 transcription (Figure 7). In the
presence of normal 3-OST-7 function, BMP signaling is
constrained to the AV junction and precluded from functional
myocardium, as reflected in high levels of P-Smad in nuclei in the
AV junction and little or no P-Smad in adjacent functional
cardiomyocytes. Since 3-OST-7 appears to be ubiquitously
expressed, the spatial regulation of BMP4 signaling is likely due
to positive feedback loops within the BMP pathway that are
constrained by 3-OST-7 function. Other studies support the idea
of positive feedback loops, showing that ectopic BMP expression
activates endogenous BMP expression in Xenopus embryos, and
correspondingly, loss of BMP ligands swirl (bmp2b), somitabun
(smad5), or snailhouse (bmp7) in zebrafish mutants results in loss of
bmp2b expression [46–49]. We do not know whether this
constraint on BMP signaling occurs by direct interaction of
BMP4 and/or its receptors with 3-OST-7 modified HSPGs, or
indirectly through other pathways, but it would be exciting in
future studies to assess if BMP4 directly bind to specifically
modified, 3-O-sulfated HSPGs. The constraint of BMP signaling
allows functional cardiomyocytes to accumulate normal levels of
tpm4 mRNA and Tpm4 protein, which then serves as a lynchpin
for the organization of normal contractile apparatus. The
importance of BMP regulation is evident both from the ability
of excessive BMP signaling to block cardiac contraction and the
ability of reduced BMP levels to rescue contraction in 3-OST-7
MO. In the absence of 3-OST-7 function, the normal endogenous
BMP signaling that occurs in the AV junction at 48 hpf spreads
ectopically into myocardium beyond its normal boundaries in the
AV junction, most likely mediated by the BMP receptor
BMPR2B, which we show to be ectopically expressed in 3-OST-
7 morphant hearts. This results in high levels of P-Smad in the
nucleus of ventricular myocytes. High levels of BMP signaling
result in reduced levels of tpm4 mRNA, thereby removing the
Tpm4 lynchpin and leading to failure of contractile apparatus
organization. It is not known whether the reduction of tpm4
mRNA is due to direct transcriptional suppression by the
increased levels of P-Smad in the ventricular nuclei, or to indirect
effects. Thus, although ventricular myocytes have normal cycling
calcium and electrophysiology, they are incapable of contracting.
Interestingly, other models of cardiac noncontraction (kcnh2 and
Figure 6. 3-OST-7 regulates cardiac contraction by constraining BMP signaling. (A) Tg(hs:bmp2b) heterozygotes were crossed to wild-type
zebrafish and embryos were either untreated (no hs) or heat-shocked at 12 hpf. Embryos in each group were scored for ventricular contraction, and
then genotyped for presence of heat-shock transgene. Graph depicts percentage contraction of embryos with transgene (green) or without (blue) in
each treatment group. Induction of BMP signaling led to ventricular noncontraction. (B) bmp4st72 heterozygotes were crossed and embryos were
either uninjected or injected with 3-OST-7 MO. Embryos in each group were scored for ventricular noncontraction, and then genotyped for bmp4
mutation (RE, digestion with SpeI). Graph depicts percentage contraction of each genotypic class in uninjected embryos (blue) or embryos injected
with 3-OST-7 MO (red). Ventricular noncontraction was rescued in 3-OST-7 morphants by bmp4st72 mutation.
doi:10.1371/journal.pbio.1001727.g006
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tnnt2 morphants) also display expanded expression of bmp4,
suggesting there might be an inappropriate positive feedback loop
between overexpression of BMP and a failure of cardiomyocytes to
contract. We would not expect manipulations of the BMP4
pathway to rescue ventricular noncontraction in the kcnh2 and
tnnt2 morphants or mutants, since other critical components, of
either the excitation-contraction coupling process or contractile
machinery, are still missing. It is interesting to note that zebrafish
tbx5 [50], apc [51], foxn4 [30], and tmem2 [52,53] mutants that have
a similar expansion of bmp4 expression in the ventricle also have
poor contractility, although the noncontraction phenotype in these
mutants appears to be less penetrant and have a later onset than
48 hpf. These genes have been shown to control AV canal
formation, and experiments in the tmem2 mutants have shown that
expanded bmp4 expression facilitates expansion of the AV canal
markers hyaluronan synthase 2 and Alcama [53], suggesting an
expansion of noncontracting, nonchamber myocardium. Our
results uncover a unique role for bmp4 in promoting a
Figure 7. Model for role of 3-O-sulfation catalyzed by 3-OST-7 in cardiac development. Under normal conditions, specific 3-OST-7-
dependent 3-O-sulfation patterns (pink circles) on endocardial HSPGs constrain bmp4 in nonchamber (noncontracting) myocardium (AV junction, red
compartment), allowing transcription of tpm4 in contracting myocardium (ventricle, green compartment). Tpm4 then stabilizes the sarcomere and
ensures proper contraction (Tn, troponin). Knockdown of 3-OST-7 results in loss of 3-O-sulfation, expansion of bmp4 and BMP signaling and P-Smad
delocalization into ventricular myocardium. High levels of BMP signaling lead to reduced levels of tpm4 transcripts and Tpm4 proteins, which then
disrupt sarcomere assembly and lead to noncontraction.
doi:10.1371/journal.pbio.1001727.g007
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noncontracting, nonchamber myocardium in that other markers
that distinguish between chamber and nonchamber myocardium
were normal (tbx2, anf, and notch1b). The ability of bmp4 to drive
myocardium toward noncontracting, nonchamber myocardium is
constrained by 3-O-sulfation function (Figure 7).
It is striking that the regulation of BMP signaling can be
controlled by a rare modification of 3-O-sulfation on HSPGs, and
that loss of this regulation has dramatic effects on the ability of the
heart to function. Even more striking is that other 3-OST family
members, many of which are expressed ubiquitously in these early
stages of development [16], do not compensate for the loss of 3-
OST-7. Knockdown of other 3-OST family members have distinct
phenotypes and regulate other cell signaling pathways, including
FGF signaling [18], but do not have the cardiac ventricular
contraction defect described here for 3-OST-7. The regulation of
ligand gradients and signaling by HSPG modification enzymes has
been shown in Drosophila [11,14], which has a limited number of
genes for each step in the pathway. This level of precise regulation
has not been described in vertebrates, in which each enzymatic
step has large number of family members. Here, our results suggest
that 3-OST-7 has a unique ability to generate a distinct
modification on GAG chains of HSPGs, and this modification is
necessary for the spatial regulation of BMP signaling during
cardiac development, necessary for ventricle contraction.
Materials and Methods
Zebrafish Lines and Ethics Statement
All zebrafish experiments were performed in accordance to
protocols approved by IACUC. Zebrafish were maintained under
standard laboratory conditions at 28.5uC. In addition to Oregon
AB wild-type, the following transgenic and mutant lines were used:
Tg(cmlc2:GFP) [17], (Tg(cmlc2-DsRed-nuc) [19], Tg(fli1:EGFP) [22],
Tg(cmcl2:gCaMP)s878 [26], Tg(hsp70:bmp2b) [44], Tg(BRE:d2GFP)
[42], bmp4st72 [45], and deltaD/aeiAG49 [37].
Morpholino Injection
MO oligonucleotides were obtained from Gene Tools, LLC.
The following sequences and concentrations were used: transla-
tion-blocking 3-OST-7 MO1, 59-CACATAACTCAGAAGATT-
GGCCATG-39, 5.4 ng; splice-blocking 3-OST-7 MO2, 59-
CACATCTGGAAGACACAAGAGAGAG-39, 1.8 ng; 3-OST-5
MO, 59-GTCCAGTCAGGTCAAGGGCAGCTCA-39, 2.7 ng;
3-OST-3Z MO, 59-GTCCAGTCAGGTCAAGGGCAGCTCA-
39, 5.4 ng; translation-blocking kcnh2MO [24], 2.3 ng; translation-
blocking tnnt2 MO [43], 4 ng; translation-blocking fgfr1 MO1
[54], 4 ng; and translation-blocking fgfr1 MO2 [54], 8 ng.
Embryos were injected at the 1–2 cell stage.
Transgenesis and mRNA Rescue
The Tol2kit cloning system was used to generate Tg(b-actin:3-
OST-7-IEP), Tg(cmlc2:3-OST-7-IEP), and Tg(fli1:3-OST-7-IEP).
Multisite recombination reactions were performed as previously
described [20]. Transposase RNA was synthesized using mMes-
sage mMachine kit (Ambion). 25 pg of transposase RNA and
30 pg of b-actin:3-OST-7-IEP, cmlc2:3-OST-7-IEP or fli1:3-OST-7-
IEP plasmid DNA were injected into wild-type AB fish at the one-
cell stage. Potential transgenic founders (TF) were identified by
scoring for GFP expression in hearts (cmlc2:3-OST-7-IEP and
fli1:3-OST-7-IEP) or ubiquitous GFP expression (b-actin:3-OST-7-
IEP). Potential TFs were then crossed to wild-type AB fish to check
for GFP expression. Those that gave GFP-positive transgenic
embryos were subsequently used for rescue experiments where 3-
OST-7 MO2 was injected into embryos from TF6AB matings. At
48 hpf, embryos were sorted by GFP fluorescence, then scored for
ventricular noncontraction.
For tpm4 rescue experiments, tpm4 RNA was synthesized using
the mMessage mMachine kit (Ambion) from the linearized pXT7-
tpm4-tv1 expression vector [55]. 175 pg of RNA was co-injected
with 5.4 ng of 3-OST-7 MO1 at the one-cell stage.
For tnnt2 rescue experiments, 25 pg of transposase RNA, 30 pg
of cmlc2:tnnt2-IRES-EGFP [56], and 5.4 ng 3-OST-7 MO1 were
injected into wild-type AB fish at the one-cell stage. Those that
gave GFP-positive transgenic embryos were scored for rescue of
ventricular noncontraction.
Data Acquisition and Processing for 3D Myocyte
Reconstruction
48 hpf explanted hearts were placed in physiological solution
containing 0 mM Ca2+ and 10 mM blebbistatin. The sarcolemma
was labeled using wheat germ agglutinin conjugated to Alexa
Fluor 555 (Invitrogen). Using a confocal microscope (LSM 5 Live
Duo, Carl Zeiss) equipped with a 406oil immersion lens, samples
were excited with a 543 nm laser and emission collected with a
long-pass 560 nm filter. Image stacks were acquired with a
resolution of 0.2 mm60.2 mm60.2 mm. Correction of depth-
dependent attenuation, deconvolution, and 3D reconstruction of
confocal images were performed as previously described [57].
In Situ Hybridization
Digoxigenin-labeled antisense riboprobes were synthesized
using Digoxigenin RNA Labeling Kit (Roche). cDNA plasmids
encoding hand2, nkx2.5, cmlc2, amhc, vmhc, tnnt2, tpm4 [55], bmp4,
versican, notch1B, anf, tbx2b, bmpr1aa (alk3a), bmpr1ab (alk3b), bmpr1ba
(alk6a), bmpr1bb (alk6b), bmpr2b, acvr1l (alk8), acvr2aa (acvr2a), acvr2b,
acvrl1 (alk1) [58], sdc2, sdc3, and sdc4 were used. ISH were
performed as previously described [59], with anti-digoxigenin
antibody incubation carried out using a Biolane HTI machine.
Embryos were cleared in 70% glycerol and photographed with a
Nikon SMZ1000 camera. Digital images were processed with
Adobe Photoshop CS4.
Calcium Transient Recording
Ca2+ transients were recorded as previously described [60].
Fluorescent signals (F) were normalized to baseline values (Fo). The
maximum Ca2+ transient amplitude (FMax/Fo) was determined by
averaging the peak amplitude of three consecutive transient
signals. The decay of the calcium transient was determined by a
monoexponential fit of the decaying signal and averaging value of
three consecutive transient signals.
Optical Mapping
48 hpf zebrafish was placed on a coverglass. Electromechan-
ical isolation was achieved with 2,3-BDM (Sigma) at 10 mmol/l
applied 15 minutes before imaging. Single plane widefield
epifluorescence images of the heart were obtained with a Nikon
TE-2000 inverted microscope using a 406 Plan Apo air
objective, Xcite-120 (Exfo) widefield epifluorescent source and
standard FITC filter set. Images were acquired with a Coolsnap
HQ camera (Photometrics) using Metavue software (Molecular
Devices) in stream acquisition mode at a frame rate of 30 ms/
frame (5126512 pixels). Image processing consisted first of
manual adjustment of minor spatial shifts of the image over a
temporal imaging series. Then, the fluorescence intensity of
each pixel in a 2D map was normalized to its percentage
between the minimum and maximum recorded values of the
pixel over the full series. Isochronal lines at 20 ms intervals were
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obtained by identifying the maximal spatial gradient for a given
time point. The color-coded scheme in each panel and video
describes progressive activation of the heart with white/red cells
and black/blue cells indicating depolarization and repolariza-
tion, respectively. Software processing was performed with
Metavue software and procedures written in MATLAB
(MathWorks).
Immunohistochemistry
IHC using the primary antibodies MF20 (Developmental
Studies Hybridoma Bank, 1:10), CT3 (Developmental Studies
Hybridoma Bank, 1:10), CH1 (Developmental Studies Hybridoma
Bank, 1:10), and P-Smad1/5/8 (Cell Signaling Technology, 1:100)
was performed as previously described [54]. Secondary antibody,
either donkey anti-mouse AlexaFluor488 (Molecular Probes) or
goat anti-mouse AlexaFluor488 (Molecular Probes), was used in
1:100 dilution. Images were acquired using an Olympus Fluoview
FV300 laser scanning confocal microscope. Digital images were
processed with Adobe Photoshop CS4.
Rescue in Bmp4st72 Embryos
Embryos from bmp4st72/+6bmp4st72/+matings were injected with
3-OST-7MO. At 48 hpf, the hearts were scored for noncontracting
ventricle or wild-type phenotype. Genomic DNA was extracted
from each individual embryo and genotyped using the following
dCAPS primers, 59-TGGTGAGGCACAACACCTCCAACTAG-
39 (forward) and 59-CCGAGTCAGCGGGTGACTTTTG-
CCGTC-39 (reverse). The PCR products were digested with SpeI
(NEB) and ran in 3% agarose gel. Digestion with SpeI releases
250 bp band in wild-type, 230 bp band in mutant, and both in
heterozygotes. DNA genotyped to be from mutants were sequenced
to verify compatibility with 3-OST-7 MO.
Statistics
Statistical significance was analyzed using Student’s t-test.
Analysis was performed using GraphPad Prism (version 6.00 for
Mac GraphPad Software). Results are considered significant when
p,0.05 and results are expressed as mean 6 standard error of the
mean (SEM).
Supporting Information
Figure S1 Heart field specification proceeds normally
in 3-OST-7 morphants. Dorsal views (anterior on top) of
control (uninjected, wild-type) (A, C, E, and K), control MO
(injected with control 3-OST-3Z MO) (G and I), and 3-OST-7
morphant (B, D, F, H, J and L) embryos; n=35 for each group.
ISHs for: lateral plate mesoderm marker hand2 (A and B, 17 hpf)
and cardiac precursor cell marker nkx2.5 (C and D, 17 hpf),
myocardial precursor cell marker cmlc2 (E and F, 17 hpf), atrial
precursor cell marker amhc (I and J, 20 hpf), and ventricular
precursor cell marker vmhc (K and L, 18 hpf) showed comparable
levels and patterns of expression in control and 3-OST-7
morphant embryos. Imaging of fli1 expression in Tg(fli1:EGFP)
zebrafish at 18 hpf revealed endocardial lineage is intact in 3-
OST-7 morphant embryos (G and H).
(TIF)
Figure S2 Knockdown of 3-OST-7 disrupts sarcomere
organization.Whole mount IHC using anti-myosin (MF20) and
phalloidin revealed myosin and actin filaments were disorganized
in ventricles of 3-OST-7 morphants (B and D) compared with
control (A and C) (n=30 for each group). At, atrium; V, ventricle.
(TIF)
Figure S3 3-OST-7 controls transcript levels of tpm4 but
not those of tnnt2. In situ analysis for tnnt2 showed comparable
transcript levels and patterns of expression for 3-OST-7 morphants
(B, F, and J) and control (injected with control 3-OST-3Z MO)
embryos (A, E, and I) at 20 hpf (A and B), 24 hpf (E and F), and
48 hpf (I and J). In contrast, tpm4 transcripts were decreased in 3-
OST-7 morphants (D and H) compared to control embryos (C and
G) at 20 hpf (C and D) and 24 hpf (G and H). (A–D) are dorsal
views with anterior on top; (E–J) are ventral views with anterior on
top; n=40 for each group. At, atrium; V, ventricle.
(TIF)
Figure S4 Overexpression of tpm4 rescues the noncon-
tracting ventricle phenotype in 3-OST-7 morphant
embryos. Overexpression of tpm4 in control embryos did not
alter cardiac function. Strikingly, overexpression in 3-OST-7
morphants rescued ventricular noncontraction (p=0.0097).
(TIFF)
Figure S5 Overexpression of tnnt2 using transient
cmlc2:tnnt2-IRES-EGFP plasmid expression does not
rescue the noncontracting ventricle phenotype in 3-
OST-7 morphant embryos. Tnnt2 transgene expression was
scored by EGFP expression. Injection of plasmid alone (blue bar)
did not perturb ventricular contraction similar to control (white
bar). Injection of both plasmid and 3-OST-7 MO (green bar)
resulted in ventricular noncontraction at a percentage similar to
injection of 3-OST-7 MO alone (red bar) (NS, p=0.69).
(TIFF)
Figure S6 Disrupting the FGF and Notch signaling
pathways do not phenocopy the noncontracting ven-
tricle phenotype of 3-OST-7 knockdown. (A) Table
showing percentage of normal contraction and small ventricles
in control (uninjected) embryos, embryos injected with 4 ng
fgfr1 MO1, and embryos injected with 8 ng fgfr1 MO2 at
48 hpf. Ventricular contraction appeared normal in all groups.
(B) Timeline showing the time and duration of 75 mm DAPT
treatment and table showing percentage of embryos with
normal contraction. Control embryos were treated with 0.3%
(v/v) DMSO. Ventricular contraction appeared normal in all
treatments. To ensure DAPT was working, embryos treated
with DAPT starting at 5 hpf were observed at 18 hpf for
somite defects. All embryos that received DAPT treatment
starting at this timepoint developed somite defects at 18 hpf.
No somite disruption was observed in corresponding DMSO
treatments.
(TIF)
Figure S7 Knockdown of 3-OST-7 affects expression
pattern of versican but does not alter expression
patterns of other heart differentiation markers at
48 hpf. ISH for versican, an AV myocardium-localized marker,
showed ectopic expression in ventricular myocardium of 3-OST-7
morphants (A and B). Expression of anf, a marker for chamber
myocardium, was comparable between control and 3-OST-7
morphants (C and D). Tie2 expression, assessed in Tg(tie2:EGFP)
embryos, was normally expressed in 3-OST-7 morphant AV
endocardium (F) and is similar to control (E). Control groups (A
and C) were injected with control 3-OST-3Z MO, control (E) was
uninjected. V, ventricle; At, atrium; red arrows point to AV;
dashed white lines outline the heart.
(TIF)
Figure S8 Knockdown of 3-OST-7 alters expression
patterns of BMP receptors bmpr2b and alk8. ISH for
bmpr2b (A, C) showed ectopic expression in heart (C, red arrow) of
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3-OST-7 morphant. ISH for alk8 (B, D) showed ectopic expression
in outflow tract (D, red arrow) of 3-OST-7 morphant.
(TIF)
Table S1 Action potential parameters recorded from
control (uninjected, wild-type) embryos and 3-OST-7
morphants.
(DOCX)
Table S2 Statistical t-test comparison of action poten-
tial parameters between control (uninjected, wild-type)
embryos and 3-OST-7 morphants.
(DOCX)
Table S3 ISH analysis comparing expression of nine
BMP receptors in control wild-type and 3-OST-7 mor-
phants.
(DOCX)
Table S4 Heat-shock of embryos from Tg(hs:bmp2b)/
+6wild-type cross at 24 hpf and 36 hpf.
(DOCX)
Video S1 Lateral view of beating heart in control
(uninjected, wild-type) Tg(cmlc2:gfp) embryo at 48 hpf.
Ventricle is left, atrium is right.
(MOV)
Video S2 Lateral view of impaired ventricular contrac-
tion in 3-OST-7 morphant Tg(cmlc2:gfp) embryo at
48 hpf. Ventricle is left, atrium is right.
(MOV)
Video S3 Normal circulation in the trunk of control
(uninjected, wild-type) embryo.
(MOV)
Video S4 Poor blood circulation in the trunk of 3-OST-7
morphant embryo.
(MOV)
Video S5 Calcium waves in explanted heart stained
with Fluo-4 of control (injected with control 3-OST-5
MO) embryo. Ventricle is right, atrium is left.
(MOV)
Video S6 Calcium waves in explanted heart stained
with Fluo-4 of 3-OST-7 morphant embryo. Ventricle is
right, atrium is left.
(MOV)
Video S7 Calcium activation and progression of con-
duction in control (injected with control 3-OST-3Z MO)
Tg(cmlc2:gCaMP)s878 embryo. Atrium is on top.
(MOV)
Video S8 Calcium activation and progression of con-
duction in 3-OST-7 morphant Tg(cmlc2:gCaMP)s878
embryo. Atrium is slightly out of focus on top.
(MOV)
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